胸腺素组份5能纠正细胞兔疫缺陷、改善临床状况,因此推测胸腺素对肿瘤患者治疗可能有益.因为患肿瘤及常规抗癌治疗时常伴有细胞免疫缺陷.本文检查了正常人、未经治疗的、正在用放疗或化疗的以及临床痊愈的实体肿瘤患者的血标本1500余份,测其原始E玫瑰花结形成率及体外加胸腺素作用后的E玫瑰花结形成率,以了解其T细胞水平.结果,原来T细胞值低者,加胸腺素后 Thymosin component 5 can correct the immune deficiency of cells and improve the clinical status, so we suppose that thymosin may be beneficial to the treatment of cancer patients because of the tumor and conventional anti-cancer treatment often accompanied by cellular immune deficiency.This paper examined the normal, without Treatment, are using radiotherapy or chemotherapy and clinical recovery of solid tumor patients with blood samples of more than 1500, measured the rate of formation of the original E-rosette and thymosin addition in vitro after the formation rate of E-rosette to understand its T cell levels.As a result, the original low T cells, after adding thymosin